← Open Payments lookup

CAMIL KREIT: Open Payments

NPI 1558423780 · CLEVELAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,777 in 131 payments from 34 companies in 2025. Trend: 2023 $3,333 · 2024 $2,457 · 2025 $2,777

Food & beverage: $2,592Education: $185
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.17$387
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$179
GlaxoSmithKline, LLC.9$177
Dexcom, Inc.20$171
AstraZeneca Pharmaceuticals LP2$150
Axsome Therapeutics, Inc.7$145
ABBVIE INC.5$123
Mannkind Corporation3$107
HARMONY BIOSCIENCES LLC1$100

Products named: Kerendia, CAPLYTA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, XIFAXAN, BREZTRI, AFREZZA, INSPIRE.

Industry payments across TX — which companies pay providers there.